BI Asset Management Fondsmaeglerselskab A/S
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1778131
KOBENHAVN, G7
Position in HALO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,167,686
+$6,553,845 QoQ
Shares Held
206,563
+38.9% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#90
of 667 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $75,123,826 across 13 Biotechnology names. HALO ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,137 | $17,453,602 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
206,563 | $16,167,686 | |
| 3 | EXEL |
Exelixis, Inc.
|
274,867 | $14,955,513 | |
| 4 | INCY |
Incyte Corp
|
113,231 | $12,835,866 | |
| 5 | INSM |
INSMED Inc
|
46,033 | $4,908,038 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,132 | $3,200,007 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,097 | $2,136,409 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
25,727 | $2,039,893 |
All Filings in HALO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,167,686 | 206,563 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $9,613,841 | 148,752 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $16,565,423 | 246,143 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $21,191,739 | 288,952 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $23,146,142 | 444,947 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,832,524 | 373,492 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $20,424,766 | 427,207 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $16,852,142 | 294,412 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,237,371 | 23,632 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $592,992 | 14,577 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $4,680,429 | 126,635 | Shares | Defined | 2024-02-09 | |
| 2023-03-31 | $127,249 | 3,332 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $195,906 | 3,443 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||